DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Erbitux (Cetuximab) - Disability - Suspected Cause - Side Effect Reports

 
 



Index of reports > Disability (19)

Below is the selection of side effect reports (a.k.a. adverse event reports) related to Erbitux (Cetuximab) disability. The selected reports were submitted to the FDA during the sample period of about a year.

Possible Erbitux side effects in 73 year old male

Reported by a consumer/non-health professional from Germany on 2012-08-16

Patient: 73 year old male, weighing 91.0 kg (200.2 pounds)

Reactions: Amaurosis, Rash, Iritis

Adverse event resulted in: hospitalization, disablity

Drug(s) suspected as cause:
Erbitux

Other drugs received by patient: Pregabalin; Doxycycline HCL; Dexamethasone; Leucovorin Calcium; Fluorouracil; Flupirtine Maleate; Laxans; Glimepiride; Morphine Sulfate



Possible Erbitux side effects in 69 year old male

Reported by a physician from Japan on 2012-06-27

Patient: 69 year old male, weighing 49.0 kg (107.8 pounds)

Reactions: Paronychia, Dysgeusia, Stomatitis, Diarrhoea, Acne, Decreased Appetite

Adverse event resulted in: life threatening event, disablity

Drug(s) suspected as cause:
Fluorouracil
    Dosage: iv bolus 19mar-2apr12-600mg 1in2wk
    Indication: Colon Cancer
    Start date: 2012-03-05
    End date: 2012-04-02

Oxaliplatin
    Indication: Colon Cancer
    Start date: 2012-03-05
    End date: 2012-04-02

Erbitux
    Dosage: 12mar-2apr12 dose reduced to 375mg recent inf 2apr12
    Indication: Colon Cancer
    Start date: 2012-03-05
    End date: 2012-03-05

Leucovorin Calcium
    Indication: Colon Cancer
    Start date: 2012-03-05
    End date: 2012-04-02



Possible Erbitux side effects in 47 year old male

Reported by a consumer/non-health professional from United States on 2012-06-08

Patient: 47 year old male, weighing 56.0 kg (123.2 pounds)

Reactions: Palmar-Plantar Erythrodysaesthesia Syndrome, Rash

Adverse event resulted in: disablity

Drug(s) suspected as cause:
Erbitux
    Dosage: interrrupt on 23feb21.day 1 of cycle 1 only restat on 18apr2012
    Indication: Head and Neck Cancer
    Start date: 2012-02-23
    End date: 2012-05-17

Cisplatin
    Dosage: day 1
    Indication: Head and Neck Cancer
    Start date: 2012-02-23

Fluorouracil
    Dosage: days 1-4
    Indication: Head and Neck Cancer
    Start date: 2012-02-23



Possible Erbitux side effects in 69 year old male

Reported by a consumer/non-health professional from Japan on 2012-06-08

Patient: 69 year old male, weighing 49.0 kg (107.8 pounds)

Reactions: Paronychia, Dysgeusia, Stomatitis, Diarrhoea, Acne, Decreased Appetite

Adverse event resulted in: life threatening event, disablity

Drug(s) suspected as cause:
Leucovorin Calcium
    Indication: Colon Cancer
    Start date: 2012-03-05
    End date: 2012-04-02

Erbitux
    Dosage: 12mar-2apr12 dose reduced to 375mg recent inf 2apr12
    Indication: Colon Cancer
    Start date: 2012-03-05
    End date: 2012-03-05

Oxaliplatin
    Indication: Colon Cancer
    Start date: 2012-03-05
    End date: 2012-04-02

Fluorouracil
    Dosage: iv bolus 19mar-2apr12-600mg 1in2wk
    Indication: Colon Cancer
    Start date: 2012-03-05
    End date: 2012-04-02



Possible Erbitux side effects in

Reported by a physician from Germany on 2012-05-31

Patient:

Reactions: Confusional State, Motor Dysfunction, Cognitive Disorder

Adverse event resulted in: disablity

Drug(s) suspected as cause:
Erbitux

Other drugs received by patient: Irinotecan HCL; Trimeton



Possible Erbitux side effects in

Reported by a physician from Germany on 2012-05-28

Patient:

Reactions: Mucosal Inflammation, Diarrhoea, Rash, Thrombocytopenia

Adverse event resulted in: disablity

Drug(s) suspected as cause:
Erbitux

Other drugs received by patient: Fluorouracil; Leucovorin Calcium; Eloxatin



Possible Erbitux side effects in male

Reported by a physician from Japan on 2012-04-20

Patient: male, weighing 61.0 kg (134.2 pounds)

Reactions: Jaundice, Bile Duct Stenosis

Adverse event resulted in: life threatening event, hospitalization, disablity

Drug(s) suspected as cause:
Irinotecan Hydrochloride
    Dosage: dosage is uncertain.
    Indication: Rectal Cancer Recurrent

Xeloda
    Administration route: Oral
    Indication: Rectal Cancer Recurrent
    Start date: 2009-12-15
    End date: 2010-10-13

Oxaliplatin
    Dosage: dosage is uncertain.
    Indication: Rectal Cancer Recurrent
    Start date: 2009-12-15

Erbitux
    Dosage: dosage is uncertain.
    Indication: Rectal Cancer Recurrent

Other drugs received by patient: Novorapid; Lantus; Pydoxal



Possible Erbitux side effects in male

Reported by a physician from Japan on 2012-04-04

Patient: male, weighing 61.0 kg (134.2 pounds)

Reactions: Jaundice, Bile Duct Stenosis

Adverse event resulted in: hospitalization, disablity

Drug(s) suspected as cause:
Irinotecan HCL
    Dosage: dosage is uncertain.
    Indication: Rectal Cancer Metastatic

Oxaliplatin
    Dosage: dosage is uncertain.
    Indication: Rectal Cancer Metastatic
    Start date: 2009-12-15

Xeloda
    Administration route: Oral
    Indication: Rectal Cancer Metastatic
    Start date: 2009-12-15
    End date: 2010-10-01

Erbitux
    Dosage: dosage is uncertain.
    Indication: Rectal Cancer Metastatic

Other drugs received by patient: Lantus; Pydoxal; Novorapid



Possible Erbitux side effects in 79 year old male

Reported by a consumer/non-health professional from Germany on 2012-04-02

Patient: 79 year old male, weighing 62.0 kg (136.4 pounds)

Reactions: Cerebral Haemorrhage, Infusion Related Reaction

Adverse event resulted in: hospitalization, disablity

Drug(s) suspected as cause:
Erbitux

Other drugs received by patient: Polaramine; Decadron; Amlodipine; Zofran



Possible Erbitux side effects in 74 year old male

Reported by a physician from Germany on 2012-03-20

Patient: 74 year old male

Reactions: Cerebrovascular Accident

Adverse event resulted in: life threatening event, hospitalization, disablity

Drug(s) suspected as cause:
Erbitux
    Dosage: last inf: 08feb2012 total inf:840mg
    Indication: Lung Carcinoma Cell Type Unspecified Stage IV
    Start date: 2011-07-06
    End date: 2012-02-08

Erbitux
    Dosage: last inf: 08feb2012 total inf:840mg
    Indication: non-Small Cell Lung Cancer
    Start date: 2011-07-06
    End date: 2012-02-08



Possible Erbitux side effects in male

Reported by a consumer/non-health professional from United States on 2012-03-19

Patient: male

Reactions: Laryngectomy

Adverse event resulted in: hospitalization, disablity

Drug(s) suspected as cause:
Erbitux



Possible Erbitux side effects in 52 year old female

Reported by a consumer/non-health professional from Germany on 2012-03-08

Patient: 52 year old female

Reactions: Chest Pain

Adverse event resulted in: hospitalization, disablity

Drug(s) suspected as cause:
Cisplatin
    Dosage: for 55mins 18.15-19.10 last inf on 10nov11.
    Indication: non-Small Cell Lung Cancer
    Start date: 2011-09-06

Erbitux
    Dosage: last 17jan12 cancelled on 8cyc 13sep11
    Indication: non-Small Cell Lung Cancer
    Start date: 2011-09-06

Docetaxel
    Dosage: intravenous infusion for 70mins 19.15-20.25 last 10nov11.
    Indication: non-Small Cell Lung Cancer
    Start date: 2011-09-06

Other drugs received by patient: Tramadol Hydrochloride; Metoclopramide; Enoxaparin Sodium; Voltaren; Granisetron Hydrochloride; Prednisolone; Levofloxacin; Calcium Carbonate; Pantoprazole; Promethazine HCL; Levothyroxine Sodium; Pentasa; Haloperidol



Possible Erbitux side effects in 79 year old male

Reported by a consumer/non-health professional from Germany on 2012-03-07

Patient: 79 year old male, weighing 62.0 kg (136.4 pounds)

Reactions: Loss of Consciousness, Cerebral Haemorrhage

Adverse event resulted in: hospitalization, disablity

Drug(s) suspected as cause:
Erbitux

Other drugs received by patient: Polaramine; Decadron; Zofran; Amlodipine



Possible Erbitux side effects in male

Reported by a consumer/non-health professional from United States on 2012-03-07

Patient: male

Reactions: Laryngectomy

Adverse event resulted in: hospitalization, disablity

Drug(s) suspected as cause:
Erbitux



Possible Erbitux side effects in 52 year old female

Reported by a health professional (non-physician/pharmacist) from Germany on 2012-02-26

Patient: 52 year old female

Reactions: Chest Pain

Adverse event resulted in: hospitalization, disablity

Drug(s) suspected as cause:
Erbitux
    Dosage: last 17jan12 cancelled on 8cyc 13sep11
    Indication: non-Small Cell Lung Cancer
    Start date: 2011-09-06

Cisplatin
    Dosage: for 55mins 18.15-19.10 last inf on 10nov11.
    Indication: non-Small Cell Lung Cancer
    Start date: 2011-09-06

Docetaxel
    Dosage: intravenous infusion for 70mins 19.15-20.25 last 10nov11.
    Indication: non-Small Cell Lung Cancer
    Start date: 2011-09-06

Other drugs received by patient: Pantoprazole; Levofloxacin; Levothyroxine Sodium; Voltaren; Promethazine HCL; Metoclopramide; Prednisolone; Kevatril; Haloperidol; Enoxaparin Sodium; Calcium Carbonate; Tramadol Hydrochloride; Pentasa



Possible Erbitux side effects in 52 year old female

Reported by a consumer/non-health professional from Germany on 2012-02-12

Patient: 52 year old female

Reactions: Chest Pain

Adverse event resulted in: hospitalization, disablity

Drug(s) suspected as cause:
Erbitux
    Indication: non-Small Cell Lung Cancer
    Start date: 2011-09-06
    End date: 2012-01-17

Cisplatin
    Indication: non-Small Cell Lung Cancer
    Start date: 2011-09-06
    End date: 2011-11-10

Docetaxel
    Dosage: intravenous infusion
    Indication: non-Small Cell Lung Cancer
    Start date: 2011-09-06
    End date: 2011-11-10



Possible Erbitux side effects in 52 year old female

Reported by a health professional (non-physician/pharmacist) from Germany on 2012-01-29

Patient: 52 year old female

Reactions: Chest Pain

Adverse event resulted in: hospitalization, disablity

Drug(s) suspected as cause:
Cisplatin
    Indication: non-Small Cell Lung Cancer
    Start date: 2011-09-06

Erbitux
    Indication: non-Small Cell Lung Cancer
    Start date: 2011-09-06

Docetaxel
    Indication: non-Small Cell Lung Cancer
    Start date: 2011-09-06



Possible Erbitux side effects in 59 year old male

Reported by a health professional (non-physician/pharmacist) from Germany on 2011-12-26

Patient: 59 year old male

Reactions: Dermatitis Acneiform, Skin Necrosis

Adverse event resulted in: disablity

Drug(s) suspected as cause:
Erbitux

Other drugs received by patient: Solu-Medrol; Zofran; Soludecadron; Mannitol; Cisplatin; Polaramine; Fluorouracil



Possible Erbitux side effects in male

Reported by a consumer/non-health professional from Germany on 2011-11-08

Patient: male

Reactions: Metastases To Spine

Adverse event resulted in: disablity

Drug(s) suspected as cause:
Erbitux

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2012